Skip to main content
. 2022 Jun 20;22(3):e21. doi: 10.4110/in.2022.22.e21

Table 1. List of activators and inhibitors of SIRT1.

Type Modulator Function Model Reference
Activator Resveratrol Increase mitophagy Osteoporosis rats (69)
Quercetin Suppress NLRP3 inflammasome COVID-19 (70)
Berberine Promote autophagy of peritoneal macrophages Atherosclerosis (73)
Metformin Activate autophagy, mitigates cartilage degradation Mouse osteoarthritis (74)
Melatonin Regulate apoptosis and autophagy Sepsis-induced cardiac dysfunction (75)
SRT1720 Partially attenuate fibrosis and apoptosis Fibrotic kidney disease (72)
SRT1460 Weaken oxidative stress Myocardial ischemia/reperfusion injury (71)
SRT2183 Induce autophagy Ovarian cancer cells (76)
Inhibitor EX-527 Induced cell apoptosis Glioma (77)
Tenovin-1 Induce a nonlinear apoptosis-inducing factor-dependent cell death p53 null Ewing’s sarcoma cell line (78)
Tenovin-6 Induced apoptosis and cell cycle arrest Primary effusion lymphoma (79)
Cambinol Inhibit proliferation and induce apoptosis Myeloma cell lines (80)
Sirtinol Protect the allograft from inflammatory cell infiltration Mouse cervical heterotopic heart transplantation (81)
Salermide Induce autophagy in human NSCLC cells NSCLC (82)
Splitomicin Enhance the yield of specific hematopoietic lineage cells from embryonic stem cells Hematopoietic differentiation of embryonic stem cells (83)
NAM Increase the sensitivity of chronic myeloid leukemia to doxorubicin Chronic myeloid leukemia (84)